• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study.

作者信息

Mason Kayleigh J, Alabas Oras A, Dand Nick, Warren Richard B, Reynolds Nick J, Barker Jonathan N W N, Yiu Zenas Z N, Smith Catherine H, Griffiths Christopher E M

机构信息

Division of Musculoskeletal and Dermatological Sciences, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, UK.

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK.

出版信息

Br J Dermatol. 2024 Feb 16;190(3):441-444. doi: 10.1093/bjd/ljad446.

DOI:10.1093/bjd/ljad446
PMID:37952181
Abstract
摘要

相似文献

1
Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study.银屑病首次生物单药治疗的“超级反应者”和“超级无反应者”特征：一项巢式病例对照研究
Br J Dermatol. 2024 Feb 16;190(3):441-444. doi: 10.1093/bjd/ljad446.
2
Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide study.全国性研究：生物治疗难治性银屑病和超应答者的流行情况及特征。
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1284-1291. doi: 10.1111/jdv.18126. Epub 2022 Apr 12.
3
Predictors of Psoriasis Area and Severity Index 100 response in Korean patients with moderate-to-severe plaque psoriasis receiving biologics.预测生物制剂治疗中重度斑块状银屑病韩国患者达到银屑病面积和严重程度指数 100 缓解的因素。
Eur J Dermatol. 2023 Oct 1;33(5):518-523. doi: 10.1684/ejd.2023.4555.
4
Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case-Control Study.接受生物制剂治疗银屑病患者中银屑病关节炎的发生率：一项巢式病例对照研究。
Arthritis Rheumatol. 2022 Feb;74(2):237-243. doi: 10.1002/art.41946. Epub 2021 Dec 21.
5
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis.中重度斑块型银屑病患者接受替度鲁单抗治疗早期 PASI 应答的临床意义和预测价值。
J Dermatolog Treat. 2022 May;33(3):1670-1675. doi: 10.1080/09546634.2021.1898528. Epub 2021 Mar 18.
6
Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment: a real-life cohort study on the effectiveness and drug survival over one-year.阿达木单抗治疗银屑病中超应答者与非超应答者的比较：一项关于一年有效性和药物生存的真实队列研究。
J Dermatolog Treat. 2024 Dec;35(1):2331782. doi: 10.1080/09546634.2024.2331782. Epub 2024 Mar 21.
7
Cost-effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany.在德国，与其他生物制剂相比，司库奇尤单抗作为中度至重度银屑病的一线生物治疗的成本效益。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2191-2199. doi: 10.1111/jdv.15047. Epub 2018 Jun 27.
8
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study.抗白介素 17 和抗白介素 23 生物药物治疗头皮银屑病：单中心回顾性对比研究。
Dermatol Ther. 2022 Feb;35(2):e15228. doi: 10.1111/dth.15228. Epub 2021 Nov 30.
9
Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry.银屑病全身治疗的联合应用：来自Corrona银屑病登记处的基线特征
J Drugs Dermatol. 2019 Aug 1;18(8):731-740.
10
Outcomes associated with the use of biologic agents in moderate to severe psoriasis.与在中度至重度银屑病中使用生物制剂相关的结果。
J Drugs Dermatol. 2007 Mar;6(3):259-67.

引用本文的文献

1
Serum IL-18/IL-13 Ratio Predicts Super Response to Secukinumab in Patients with Psoriasis.血清白细胞介素-18/白细胞介素-13比值可预测银屑病患者对司库奇尤单抗的超敏反应。
Int J Mol Sci. 2025 Jul 3;26(13):6432. doi: 10.3390/ijms26136432.
2
Novel Approach for Evaluating the Effectiveness of Biological Drugs in Patients with Plaque Psoriasis: Real-World Experience of a Single-Centre Study in Poland.评估生物药物对斑块状银屑病患者有效性的新方法：波兰一项单中心研究的真实世界经验
Clin Cosmet Investig Dermatol. 2025 Jun 27;18:1615-1624. doi: 10.2147/CCID.S517656. eCollection 2025.
3
Multiple Biologics Treatment Failures in Patients with Psoriasis: A Case Series of 4 Patients.
银屑病患者多种生物制剂治疗失败：4例病例系列报道
Acta Derm Venereol. 2025 Mar 9;105:adv42987. doi: 10.2340/actadv.v105.42987.